Skip to content

Clinical trials

Completed Multiple Sclerosis, Relapsing-Remitting trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Completed Country / region: Canada Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20051
20063
20077
20084
20094
20103
20112
20121
20135
20141
20155
20163
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen12
Bayer4
Genzyme, a Sanofi Company4
Genentech, Inc.2
GlaxoSmithKline2
McGill University2
Novartis2
Novartis Pharmaceuticals2
Sanofi2
Tanabe Pharma Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting45
Multiple Sclerosis22
Demyelinating Diseases3
Recurrence3
Autoimmune Diseases2
Autoimmune Diseases of the Nervous System1
Demyelinating Autoimmune Diseases, CNS1
Diffuse Cerebral Sclerosis of Schilder1
Disease Progression1
Immune System Diseases1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.